Document is current
Any future updates will be listed below
-
Authors
An, Bolin https://orcid.org/0009-0003-2750-2609
Tang, Tzu-Chieh https://orcid.org/0000-0002-6215-8714
Zhang, Qian
Wang, Teng https://orcid.org/0009-0000-5176-5095
Wang, Yanyi
Gan, Kesheng
Liu, Kun
Zhang, Daniel L.
Liu, Yuzhu
Pan, Yu Kui
Yu, Min
Shaw, William M.
Liang, Qianyi
Wang, Yaomin
Vaiana, Christopher A.
Lou, Chunbo
Voigt, Christopher A. https://orcid.org/0000-0003-0844-4776
Lu, Timothy K.
Church, George M. https://orcid.org/0000-0001-6232-9969
Zhong, Chao https://orcid.org/0000-0002-6638-3652
- License Information
-
More Information
Article History
Received: 2 December 2024
Accepted: 10 February 2026
First Online: 18 March 2026
Competing interests
: T-C.T. is a cofounder and equity holder of Anthology. T.K.L. is a cofounder of Senti Biosciences, Synlogic, Engine Biosciences, Tango Therapeutics, Corvium, BiomX, Eligo Biosciences, Bota.Bio, Avendesora and NE47Bio. T.K.L. also holds financial interests in nest.bio, Armata, IndieBio, MedicusTek, Quark Biosciences, Personal Genomics, Thryve, Lexent Bio, March Therapeutics, Serotiny, Avendesora and Pulmobiotics. C.Z. is a cofounder and equity holder of Shenzhen PAM 2 L Biotechnologies. T.-C.T., B.A. and C.Z. are preparing a patent application (PCT/CN2025/123958) on behalf of Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. The remaining authors declare no competing interests.
